VPS9D1-AS1

gene
On this page

Also known as MYUFAISL

Summary

VPS9D1-AS1 (VPS9D1 antisense RNA 1, HGNC:48915) is a long non-coding RNA gene on chromosome 16q24.3.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:48915
Approved symbolVPS9D1-AS1
NameVPS9D1 antisense RNA 1
Location16q24.3
Locus typeRNA, long non-coding
StatusApproved
AliasesMYU, FAISL
Ensembl geneENSG00000261373
Ensembl biotypelncRNA
Entrez100128881
RNAcentralURS000003F392 — lncRNA, 1753 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 lncRNA

ENST00000562298, ENST00000562866

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000562298 — 2 exons

ExonStartEnd
ENSE000025804828971652889716637
ENSE000025935958971734489718164

Expression profiles

Bgee: expression breadth ubiquitous, 154 present calls, max score 89.57.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.8283 / max 192.1120, expressed in 1296 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1556399.82391217
1556382.6185963
1556400.3859204

Top tissues by expression

242 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548889.57gold quality
lower esophagus mucosaUBERON:003583485.74gold quality
right uterine tubeUBERON:000130278.89gold quality
esophagus mucosaUBERON:000246977.36gold quality
granulocyteCL:000009477.25gold quality
mucosa of transverse colonUBERON:000499175.76gold quality
right hemisphere of cerebellumUBERON:001489074.37gold quality
left adrenal gland cortexUBERON:003582573.81gold quality
left adrenal glandUBERON:000123473.26gold quality
stromal cell of endometriumCL:000225573.21gold quality
cerebellar hemisphereUBERON:000224572.55gold quality
vermiform appendixUBERON:000115472.49gold quality
cerebellar cortexUBERON:000212972.43gold quality
bone marrow cellCL:000209272.37silver quality
right adrenal glandUBERON:000123372.19gold quality
right adrenal gland cortexUBERON:003582771.79gold quality
right lobe of liverUBERON:000111471.42gold quality
metanephros cortexUBERON:001053371.37gold quality
adrenal cortexUBERON:000123571.08gold quality
monocyteCL:000057670.82gold quality
body of pancreasUBERON:000115070.79gold quality
cerebellumUBERON:000203770.76gold quality
spleenUBERON:000210670.70gold quality
adrenal glandUBERON:000236970.59gold quality
left ovaryUBERON:000211970.58gold quality
leukocyteCL:000073870.47gold quality
tendon of biceps brachiiUBERON:000818870.46gold quality
right ovaryUBERON:000211870.42gold quality
adenohypophysisUBERON:000219670.09gold quality
pituitary glandUBERON:000000769.03gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.78

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 11)

  • the MYU/hnRNP-K/CDK6 pathway functions downstream of Wnt/c-Myc signaling and plays a critical role in the proliferation and tumorigenicity of colon cancer cells. (PMID:27568568)
  • Data suggest that downregulated long non-coding RNA VPS9D1-AS1 may be used as a prognosis predictor of gastric cancer. (PMID:29036784)
  • Overexpression of VPS9D1-AS1 serves as a promising biomarker to predict the prognosis of non-small cell lung cancer. (PMID:30119235)
  • Study demonstrated that lncRNA MYU functions as an oncogene in prostate cancer at least in part through the miR-184/c-Myc axis. (PMID:30132573)
  • ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D. (PMID:31918265)
  • LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion. (PMID:32808668)
  • The lncRNA VPS9D1-AS1 Promotes Hepatocellular Carcinoma Cell Cycle Progression by Regulating the HuR/CDK4 Axis. (PMID:34558987)
  • VPS9D1-AS1 gene rs7206570 polymorphism associated with the clinical stage of colorectal cancer and binding with hsa-miR-361-3p. (PMID:35022999)
  • Long non-coding RNA MYU promotes ovarian cancer cell proliferation by sponging miR-6827-5p and upregulating HMGA1. (PMID:36776216)
  • LncRNA VPS9D1-AS1 regulates miR-187-3p/fibroblast growth factor receptor-like 1 axis to promote proliferation, migration, and invasion of prostate cancer cells. (PMID:37929340)
  • Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis. (PMID:38953363)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.